http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9195796-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_337c4a4e48bf26b7f711e88ecfddf883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3127c0ebee3f865b211b019fac84286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51f0648a687cc8c35ead41f6962a3364
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59c6a921f33fe0adc58c2b6177184515
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B25-10
filingDate 2009-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90aee4b0833b2177bb763b85aaf5b108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6314710fa9e81bcfb59395f7c3308e1
publicationDate 2015-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9195796-B2
titleOfInvention Malignancy-risk signature from histologically normal breast tissue
abstract The invention provides for malignancy-risk gene signatures that predict the risk of developing breast cancer, the recurrence of breast cancer, and/or the metastasis of breast cancer. These signatures have numerous clinical applications including assessing risk of breast cancer development following routine breast biopsy, assessing the need for adjuvant radiotherapy after lumpectomy, and determining the need for completion mastectomy following lumpectomy for the breast cancer patient and other treatment plans that are personalized for the patient.
priorityDate 2008-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004018525-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11789546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226540890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54232707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128674172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129881422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226540889
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3828

Total number of triples: 50.